Live feed07:30:00·915dPRReleasevia QuantisnowReviva Announces Positive Topline Results from Global Pivotal Phase 3 RECOVER Trial of Brilaroxazine in SchizophreniaByQuantisnow·Wall Street's wire, on your screen.RVPH· Reviva Pharmaceuticals Holdings Inc.Health Care